Certara, Inc.
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation s…
Medical - Healthcare Information Services
US, Princeton [HQ]
Cash Flow Statements
6 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Cash Flow (OCF) | 11.00 | 38.00 | 44.00 | 60.00 | 92.00 | 82.00 | |
| Operating Cash (Net) | 11.00 | 38.00 | 44.00 | 60.00 | 92.00 | 82.00 | |
| Accounts Receivable | -2.00 | -1.00 | -3.00 | -10.00 | -15.00 | - - | |
| Accounts Payable | -6.00 | 10.00 | 2.00 | 1.00 | 5.00 | -5.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | |
| Change | 8.00 | 8.00 | -6.00 | -2.00 | 3.00 | -4.00 | |
| Other WC | 19.00 | 2.00 | 3.00 | 7.00 | 13.00 | - - | |
| Investing Activities | |||||||
| Used Cash (Net) | -73.00 | -9.00 | -8.00 | -269.00 | -27.00 | -79.00 | |
| Capital Expenditure | -11.00 | -9.00 | -7.00 | -8.00 | -12.00 | -15.00 | |
| Purchases of Investments | - - | - - | - - | - - | - - | - - | |
| Sale/Maturity of Investment | - - | - - | - - | - - | - - | - - | |
| Property, Plant, Equipment (P&PE) | -11.00 | -9.00 | -7.00 | -8.00 | -12.00 | -15.00 | |
| Acquisitions (Net) | -62.00 | - - | - - | -261.00 | -15.00 | -64.00 | |
| Other Investing Activities | -6.00 | -7.00 | -7.00 | -7.00 | -11.00 | - - | |
| Financing Activities | |||||||
| Used Cash (Net) | -57.00 | -8.00 | -208.00 | -123.00 | -7.00 | -9.00 | |
| Debt Repayment | -8.00 | -8.00 | -124.00 | -3.00 | -3.00 | -3.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
2 | 1 | 317 | 133 | 2 | 6 | |
| Issued | 1.00 | - - | 316.00 | 133.00 | - - | - - | |
| Repurchased | -1.00 | - - | -1.00 | - - | -2.00 | -6.00 | |
| Other Financing Activities | 141.00 | - - | 36.00 | -5.00 | -1.00 | -6.00 | |
| Cash Balances | |||||||
| Begin of Period | 18.00 | 12.00 | 29.00 | 273.00 | 186.00 | 239.00 | |
| End of Period | 12.00 | 29.00 | 273.00 | 186.00 | 239.00 | 234.00 | |
| Change | -6.00 | 17.00 | 243.00 | -86.00 | 53.00 | -4.00 | |
| Non-Cash Balances | |||||||
| Depreciation and Amortization | 37.00 | 41.00 | 42.00 | 45.00 | 52.00 | 56.00 | |
| Stock Based Compensation | - - | 1.00 | 64.00 | 29.00 | 30.00 | 28.00 | |
| Other | 1.00 | 1.00 | 1.00 | 3.00 | 2.00 | 74.00 | |
| Highlighted metrics | |||||||
| Free Cash Flow (FCF) | - - | 28.00 | 36.00 | 51.00 | 80.00 | 67.00 | |
| Cash Conversion Cycle (CCC) | 114.00 | 88.00 | 64.00 | 67.00 | 77.00 | 77.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||||||
| Forex Effect on Cash | -1.00 | -2.00 | - - | - - | -4.00 | 1.00 |